XENE

insider transactions

Xenon Pharmaceuticals Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-2.5K

0 buy · 2.5K sell

Net value · 90d

-$133.5K

$0 in · $133.5K out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 2.5K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Sell·S
Jun 5, 26

Gary Patou

Director · 10b5-1

$70.3K

1.3K sh · $53.14

Own -5%
Sell·S
Jun 5, 26

Gillian Cannon

Director · 10b5-1

$63.2K

1.2K sh · $53.14

Own -45%
Grant·A
Jun 3, 26

Dawn Svoronos

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Dawn Svoronos

Director

$0

10.5K sh

Own New
Grant·A
Jun 3, 26

Gary Patou

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Gary Patou

Director

$0

10.5K sh

Own New
Grant·A
Jun 3, 26

Patrick Machado

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Patrick Machado

Director

$0

10.5K sh

Own New
Grant·A
Jun 3, 26

Justin D. Gover

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Justin D. Gover

Director

$0

10.5K sh

Own New
Grant·A
Jun 3, 26

Elizabeth A. Garofalo

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Elizabeth A. Garofalo

Director

$0

10.5K sh

Own New
Grant·A
Jun 3, 26

Steven Gannon

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Steven Gannon

Director

$0

10.5K sh

Own New
Grant·A
Jun 3, 26

Gillian Cannon

Director

$0

1.6K sh

Own New
Grant·A
Jun 3, 26

Gillian Cannon

Director

$0

10.5K sh

Own New
Exercise·M
Jun 1, 26

Dawn Svoronos

Director

$0

2.6K sh

Own New
Other·F
Jun 1, 26

Dawn Svoronos

Director

$75.6K

1.4K sh · $53.41

Own -5%
Exercise·M
Jun 1, 26

Dawn Svoronos

Director

—

2.6K sh

Own +11%
Exercise·M
Jun 1, 26

Gary Patou

Director

$0

2.6K sh

Own New
Exercise·M
Jun 1, 26

Gary Patou

Director

—

2.6K sh

Own +11%
Exercise·M
Jun 1, 26

Patrick Machado

Director

$0

2.6K sh

Own New
Exercise·M
Jun 1, 26

Patrick Machado

Director

—

2.6K sh

Own New
Exercise·M
Jun 1, 26

Justin D. Gover

Director

$0

2.6K sh

Own New
Exercise·M
Jun 1, 26

Justin D. Gover

Director

—

2.6K sh

Own New
Exercise·M
Jun 1, 26

Elizabeth A. Garofalo

Director

$0

2.6K sh

Own New
Exercise·M
Jun 1, 26

Elizabeth A. Garofalo

Director

—

2.6K sh

Own New
Exercise·M
Jun 1, 26

Steven Gannon

Director

$0

2.6K sh

Own New
Other·F
Jun 1, 26

Steven Gannon

Director

$75.6K

1.4K sh · $53.41

Own -11%
Exercise·M
Jun 1, 26

Steven Gannon

Director

—

2.6K sh

Own +25%
Exercise·M
Jun 1, 26

Gillian Cannon

Director

$0

2.6K sh

Own New
Exercise·M
Jun 1, 26

Gillian Cannon

Director

—

2.6K sh

Own New
Exercise·M
May 12, 26

Steven Gannon

Director

$0

3.5K sh

Own New
Exercise·M
May 12, 26

Steven Gannon

Director

$25.8K

3.5K sh · $7.38

Own +49%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 5, 2026	Gary Patou 10b5-1	Director	Sell S	1.3K	-5%	$53.14	$70.3K
Jun 5, 2026	Gillian Cannon 10b5-1	Director	Sell S	1.2K	-45%	$53.14	$63.2K
Jun 3, 2026	Dawn Svoronos	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Dawn Svoronos	Director	Grant A	10.5K	New	—	$0
Jun 3, 2026	Gary Patou	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Gary Patou	Director	Grant A	10.5K	New	—	$0
Jun 3, 2026	Patrick Machado	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Patrick Machado	Director	Grant A	10.5K	New	—	$0
Jun 3, 2026	Justin D. Gover	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Justin D. Gover	Director	Grant A	10.5K	New	—	$0
Jun 3, 2026	Elizabeth A. Garofalo	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Elizabeth A. Garofalo	Director	Grant A	10.5K	New	—	$0
Jun 3, 2026	Steven Gannon	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Steven Gannon	Director	Grant A	10.5K	New	—	$0
Jun 3, 2026	Gillian Cannon	Director	Grant A	1.6K	New	—	$0
Jun 3, 2026	Gillian Cannon	Director	Grant A	10.5K	New	—	$0
Jun 1, 2026	Dawn Svoronos	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Dawn Svoronos	Director	Other F	1.4K	-5%	$53.41	$75.6K
Jun 1, 2026	Dawn Svoronos	Director	Exercise M	2.6K	+11%	—	—
Jun 1, 2026	Gary Patou	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Gary Patou	Director	Exercise M	2.6K	+11%	—	—
Jun 1, 2026	Patrick Machado	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Patrick Machado	Director	Exercise M	2.6K	New	—	—
Jun 1, 2026	Justin D. Gover	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Justin D. Gover	Director	Exercise M	2.6K	New	—	—
Jun 1, 2026	Elizabeth A. Garofalo	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Elizabeth A. Garofalo	Director	Exercise M	2.6K	New	—	—
Jun 1, 2026	Steven Gannon	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Steven Gannon	Director	Other F	1.4K	-11%	$53.41	$75.6K
Jun 1, 2026	Steven Gannon	Director	Exercise M	2.6K	+25%	—	—
Jun 1, 2026	Gillian Cannon	Director	Exercise M	2.6K	New	—	$0
Jun 1, 2026	Gillian Cannon	Director	Exercise M	2.6K	New	—	—
May 12, 2026	Steven Gannon	Director	Exercise M	3.5K	New	—	$0
May 12, 2026	Steven Gannon	Director	Exercise M	3.5K	+49%	$7.38	$25.8K

About XENE insider trading

This page tracks insider transactions for Xenon Pharmaceuticals Inc. (XENE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.